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ABSTRACT
Antigen expression through the Chloroplast Transformation Technology (CTT)
produces bioencapsulated subunit-vaccines, capable of eliciting immune responses when
delivered orally. Considerable challenges to effective plant-based vaccines are the
normalization of dosage and preservation of accumulated antigen, which is complicated by
variable high water content and protease activity. This study critically examines the
efficacy of lyophilization in dehydrating plant-tissues and preserving plant-derived
antigens with vaccine potential.
Lyophilization was optimized through gravimetric analysis using lettuce expressing
Protective Antigen (PA) of Bacillus anthracis (LS-HPAG) and the human autoantigen
Proinsulin (Pins) fused to Cholera toxin subunit B (LS-CTB-Pins). Lyophilization for 48hours was sufficient treatment to reduce lettuce to 4.57% of its original weight, which
retained .058% water content in the bound state; these levels corresponded with ovendried controls while antigen was stabilized for over a year of storage at room temperature.
A simulated gastric fluid assay was applied to evaluate stability of plant derived antigens
during digestion. It was observed that lettuce plant cells conferred protection through
antigen bioencapsulation for up to an hour under enzymatic digestive conditions. LSHPAG immunogenicity was then demonstrated through the induction of a PA-specific IgG
response by through oral boosting of C57/BL6 test mice. Survival during toxin challenge
demonstrated a protective immune response if 40% of animal immunized by plant-derived
PA. Lastly, the inclusion of excipient and adjuvant additives will be considered and utilized
for the development of prototype vaccine capsule formulations.
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INTRODUCTION
Since the FDA approval of recombinant human insulin in 1982, recombinant
biopharmaceuticals have exploded into the market. Approaches utilizing the translational
machinery of diverse cell types, involving both stable and transient expression systems
have

successfully

produced

biologically

active

proteins.

Among

the

various

biopharmaceuticals produced are vaccine antigens, monoclonal antibodies, and
antimicrobials. Despite the availability of these technologies, high production costs occlude
much of the population from receiving potential treatments. These high costs stem
primarily from downstream processing which often contributes 80% of total production
costs. In light of this issue, plants offer an appealing alternative. As self-sustaining
bioreactors, all energy is derived from the sun. In addition, purification is often
unnecessary due to annulled risk of pathogen contamination.
The transformation of a plant cell can occur through the modulation of either of two
genomes: the nuclear and the chloroplast genomes [1]. Although the younger of the two,
Chloroplast Transformation Technology (CTT) holds significant promise in the realm of
bioengineering [2, 3]. A technology that owes its origins to the reintroduction of
transformed organelles to protoplast cell lines [4], chloroplast transformation now occurs
through particle delivery system of expression vectors facilitated by gold or tungsten
microparticles [5, 6]. Vectors initiate stable integration into the chloroplast genome via
homologous recombination within a targeted flanking region [7]. Integration is therefore
site-specific, and expression is normalized across homoplasmic plant lines, which have
accomplished unheralded levels of protein expression as high as 72% of the plant’s total
1

soluble protein (TSP) [8, 9]. The maternal nature of the chloroplast provides a form of
inherent gene containment, and its plasmid nature renders it free of gene silencing
mechanisms and position effects, while enabling polycistronic processing [2, 8-11]. In
addition to transcriptional advantages provided by chloroplast based expression,
translation of mRNA transcripts results in disulfide bond formation [12], lipidation, and
proper protein folding facilitated by chaperonins [13]. These properties make chloroplasts
ideal sites of synthesis for recombinant proteins.
The expression of vaccine antigens in the chloroplast was first conceived in 2001
with the expression of Cholera Toxin Subunit B in tobacco chloroplasts [14]. Since this
implementation the capacity of antigen expression has included immunogens with
bacterial, viral, plasmodial[15], and human origins[16]. Additionally, chloroplasts have
proven their capability to form highly immunogenic, complex antigen superstructures such
as virus-like-particles (VLPs) and capsomeres [17-21]. The accumulated antigen is
protected from digestion by the plant cell walls, enabling oral delivery of vaccine antigen to
target the gut mucosa [22]. Within the intestinal epithelium, resident plasmacytoid
dendritic cells of the lamina propria, as well as microfold epithelium cells, will aid in the
sampling of antigen as it passes through the gastrointestinal tract. Induction of immunity
against the vaccine antigen will occur via dendritic cell presentation to Th1 and Th2
lymphocytes, prompting inflammatory responses and activation of antibody producing B
cells in both the systemic and mucosal levels of immunity [23].
Despite the potential of this platform for oral vaccine production, the variable
expression of recombinant antigen resulting from differing water content, leaf age, and
harvest time of day limits batch consistency. Furthermore, the cold-chain transport
2

required to maintain vaccine viability contributes to growing costs and hindrances to
distribution. These issues are highlighted by the lack of plant-derived therapeutics from the
current pharmaceutical market. An effective means of plant-derived vaccine preservation is
therefore needed to make this technology practical for human use.
Lyophilization, or freeze-drying, is a common practice of the food and herbal
industries because it preserves the aesthetic appeal of plant materials and is also used by
many industries to dehydrate and concentrate certain solutions, such as purified proteins.
The effects of lyophilization on accumulated vaccine antigen were observed, as
transplastomic materials were dried. The efficacy of such freeze-dried vaccine antigens was
then examined with respect to antigen viability, gastric stability, and immunogenicity in an
effort to evaluate the efficacy of plant-mediated oral immunization.
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BACKGROUND
Chloroplast Transformation Technology
The dawn of plant genetic engineering owes itself to the discovery of a unique
bacterium, Agrobacterium tumefaciens, the causative agent of the crown gall disease, or
plant tumors. A. tumefaciens utilizes a plasmid with amazing functions to infect wounded
plants in order to produce an ecological niche for itself and its progeny. Named by the
scientists that discovered it as the Tumor inducing (Ti) plasmid, this plasmid contains a
special segment of DNA that dissociates from the Ti plasmid upon plant-cell conjugation
and autonomously inserts itself into the plant’s genomic DNA [24, 25]. This modification
serves several functions, which include the induction of several plant hormones, auxins and
cytokinins, that promote cellular proliferation and give rise to the ensuing tumor. The TDNA further diverts the endogenous metabolic pathways to favor the synthesis of unique
amino acid derivatives that only A. tumefaciens can utilize as a source of nitrogen, known
as Opines [25]. This elegant system for manipulating host DNA quickly became an
attractive platform for use in bioengineering plants with improved agricultural traits.
Eliminating the virulence genes from this plasmid and replacing them with any gene
of particular interest soon became a common technique for engineering transgenic plants.
Later, the production of binary vector systems enabled researchers to work seamlessly
with the same plasmid from Escherichia coli, to A. tumefaciens, facilitating ease in this
technique. However, widespread use of this system demonstrated the pitfalls of this
transfection method. Firstly, the site of gene integration is random. Secondly there is no
regulation over the number of integration events, resulting in widely variable gene copy
numbers in different plant lines. These events compound with each other to give rise to a
4

number of genetic occurrences that further confound the expression of a target gene. The
position of integration produces expression variability through position effects, which
influence the frequencies that certain chromosomal areas are transcriptionally accessible,
through manipulation of chromatin density. Plant cells, which by eurkaryotic nature
contain machinery necessary for regulating the chromosome complexes in cells, therefore
threaten gene-of-interest expression with gene silencing mechanisms.
This lack in control over gene insertion could possibly result in phenotype altering
pleiotropic effects that may manifest if the site of integration interrupts important
endogenous gene sequences.
The drawbacks associated with the Agrobacterium approach to genetically
modifying plants prompted researchers to investigate other methods of transformation.
Some set their eyes on the chloroplasts of plant cells, the so-called energy producer of the
cell. Beyond this organelle’s high-energy flux, many of the features of its genome made it a
very promising candidate for biotechnology applications. Indeed, most of the pitfalls
associated with nuclear genome transformants were overcome by moving the site of gene
integration to the descendant of prokaryotic cyannobacteria, the chloroplast [26].
This subcellular organelle is similar to the mitochondria in the sense that it contains
its own genome inherited from its prokaryotic ancestors. The chloroplast genome is
therefore analogous to that of a prokaryote; it is plasmid, or circular, in nature, and the only
structural organization that it is prone to is natural coiling by gyrases which is readily
reversed by topoisomerase activity. A lack of chromosomal structure translates into a lack
of gene silencing potential, which bodes well for the expression of a transgene. In addition
to being a highly polyploidy organelle, the chloroplast exists at high numbers in plant cells.
5

Each plant cell may have as many as 10,000 copies of the chloroplast genome, which offers
a tremendous potential for foreign gene expression [3].
The chloroplast however was not a target of Agrobacterium; therefore, a technique
was required that would allow integration of the gene into the genome of the chloroplast.
CTT initially began through laborious techniques that involved purifying live and intact
chloroplasts, genetically modifying them in a technique akin to bacterial transformation,
and then reintroducing those transformed chloroplasts into a plant cell, followed by the
subsequent regeneration of those plants [4]. Later, the development of Biolistic Particle
Delivery, or gene bombardment methods, greatly reduced the required labor for producing
transplastomic, or plastid-transformed, plants [5, 6]. Since its birth, gene bombardment has
matured into an optimized technique largely pioneered by the Daniell Lab, which
generated the universal chloroplast transformation vector pLD that shuttles target genes
into the chloroplast, and initiates a recombination even to transpose the target gene into
the host genome [7].
This recombination event is driven by two sequences flanking the target gene that
are homologous to sequences in the chloroplast genome. Sequence homology initiates
homologous recombination, which positions the gene of interest into the chloroplast
plasmid. This technique allows for site specific integration based on the choice of flanking
sequence, and the integration is guaranteed to happen only once per plasmid. In addition to
the gene of interest, the pLD facilitates the integration of a complete expression cassette:
this includes promoters and selectable markers, the hallmarks of any gene vector. After
bombardment, transformed cells undergo a non-lethal selection on spectinomycin
containing media [27]. Specintomycin is an aminoglycoside which inhibits protein
6

synthesis by ribosomal inhibition and therefore halts cellular proliferation [28]. Only cells
coengineered with the gene of interest will contain the spectinomycin resistance gene,
aadA. Therefore only transformants will be able to grow. Totipotent plant cells eventually
regenerate to a full plant and seeds may be collected with one hundred percent of progeny
inheriting the transgene [13]. As opposed to nuclear transformed plants that experience
mendalian inheritance of transgenes, chloroplasts genes are almost entirely maternally
inherited. This unique feature also doubles as an inherent gene containment system, as
there is no threat of pollen containing transgenes [10].
The capacity of the chloroplast to express recombinant proteins has been
demonstrated through the sheer diversity of publications that have come out of the CTT
field [1]. Initial interests were geared towards improving the agricultural viability of many
plant species. Genes conferring herbicide resistance, insecticide resistance, and pathogen
resistance were soon being introduced to plants [29, 30]; these were followed by such
traits as draught tolerance and salt tolerance in carrot [31]. Plants were rendered with
phytoremediation capabilities to remove organomercurial compounds that normally
inhibit photosynthesis in chloroplasts [32]. The potential of chloroplast biotechnology was
eventually tested in the field biopharmaceuticals. The list of accomplishments to date is
considerable, ranging from human blood proteins such as Erythropoietin [33] or IFN-γ
[12], complex monoclonal antibodies [34], even biopolymer plastics with medical
applications [11]. This platform has proven worthy of considerable attention, as it has
obtained levels of expression at biomasses unheralded by other systems in terms of cost;
plants have expressed as much as 70% of their total protein in the form of the transgene,
which translates into enormous yield of transgenic proteins [9]. Now, this platform has
7

become of interest in the context of vaccine antigen production and has been repeatedly
used in the modulation of murine immune responses in vivo.
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Anthrax, Currently Licensed Vaccines and Recombinant Protective Antigen
More commonly known as Anthrax, Bacillus anthracis is in fact a relatively common
spore-forming, gram-positive inhabitant of the soil, classified as a Category A agent by the
Centers for Disease Control [35]. Natural human infections occur rarely in developed areas
due to a lessened risk of exposure and occur at a slightly higher frequency in developing
areas; this pathogen’s primary hosts are large herbivorous mammals [36]. Human infection
typically occurs through the inhalation sporulated B. antracis and is often a result of
exposure to contaminated animal products but will ultimately result in fatal septicemia
[36]. In today’s world however, anthrax spores have become a major subject of
bioterrorism concerns as weaponized spores designed to optimize their airborne
dissemination have been developed. Strikes made against United States citizens by mailing
of anthrax spores through the United States Post Office in 2001 demonstrates the need for
effective immunization strategies applicable to the general public, and not just members of
the armed forces, which prompted major research in the characterization of B. anthracis
and its pathogenesis for development of more efficacious second generation immunization
strategies [37, 38]. Virulent B. anthracis possess extra chromosomal plasmids that bestow
them with their virulent traits. The pX01 plasmid encodes the anthrax toxins protective
antigen (PA), edema factor (EF), and lethal factor (LF) encoded by the genes pagA, cya, and
lef respectively. The second plasmid, pX02, contains the genes that produce a poly-Dglutamic acid capsule [37].
The inhalation of anthrax spores, leads to their phagocytosis by resident lung
alveolar macrophages, as well as migrating neutrophils and dendritic cells and the
progression of the early intracellular phase of infection [39, 40]. While the bactericidal
9

activity of the macrophages and neutrophils may effectively control bacterial proliferation,
the success of the endosomal conditions depends largely on the magnitude of bacterial
infection. Dendritic cells, however, are believed to favor spore germination and
consequently transport invading pathogens to the draining lymnodes of the lungs
facilitating their systemic diffusion. Once phagocytosed, the inactive spores begin
germinating and mature to the vegetative bacillus state [40]. Evasion of the mechanisms of
the phagolysozome by Bacillus anthracis is dependant on an array of defenses against APC
phagocytosis including secreted proteases, membrane proteins geared towards
neutralizing bactericidal mechanisms and optimizing nutrient uptake. Furthermore,
expression of diverse phospholipases maintains a favorable environment by inhibiting
endosomal maturation and promoting cell lysis that leads to the release of proliferating
cells and the onset of a systemic infection. This release of the active vegetative bacterium
into the blood stream characterizes phase II or the systemic anthrax infection [35].
In circulation, Bacillus anthracis begins secretion of the anthrax toxin. Anthrax toxin
(Atx) is a three component protein-translocase system designed to modify cellular activity
through the modification of cytoplasmic molecules and promote the eventual lysis of the
host leukocytes and overall immune dysfunction [39, 41]. Protective Antigen (PA) forms
homoheptameric structures as well as oligomers with the other toxin components Edema
Factor (EF) and Lethal Factor (LF). Upon secretion Atx targets a variety of endogenous
receptors that function as the Anthrax toxin receptor and facilitate the endocytosis of this
pathogenic complex. Internalization initiates toxin activation, as the PA subunits undergo
furin-based proteolytic clevage, as well as pH-dependant conformational activation before
the heptameric PA structure enters a ring-like conformation and internalizes with the
10

membrane of the endosome to form a trans-membrane pore at which point EF and LF are
secreted into the cytosol [40]. EF possesses adenyl cyclase activity and impairs host
defenses, particularly phagocytosis, while LF is a zinc dependant metalloprotease that
inhibits mitogen-activated protein kinase kinase (MAPKK) and results in cellular lysis [40].
Systemic proliferation of this bacterium promotes further pathogensis of other cell types as
multiple other receptors for PA have been identified such as capillary morphogenesis
protein 2 (CMG2) or tumor endothelial cell marker 8 (TEM8) [38].
As the spearhead facilitating systemic B. anthracis infection, the Atx system became
the target of immunization strategies against anthrax, as its inhibition would effectively
neutralize the major virulence factors and halts the proliferation and anthrax [35, 36].
Currently, there are two commercially available anthrax vaccines that are produced
through similar approaches: the Anthrax Vaccine Adsorbed (AVA) in the United States and
the Anthrax Vaccine Precipitated (AVP) in Europe [36]. AVA, produced by BioPort
Corporation of Michigan in 1970 under the trade name BioThrax, induces protective B-cell
mediated immunity within three to six doses. AVA is an acellular preparation of B.
anthracis cultures prepared through culture filtration and adsorbed onto an aluminum
resin, containing Atx as the “subunit” through which the protective response is conferred.
EF and LF components, however, result in severe reactogenicity in 20% of patients
characterized by erythema, soreness, and fever, with serious adverse effects in 1% of
patients [36]. AVP, licensed through the Center for Applied Microbiology and Research of
Great Britain in 1979, contains both only PA and LF. AVP requires several
primovaccinations followed by a six-month boost of antigen and apparently delivers milder
side effects. The severe reactions experienced y recipients of this vaccination highlight the
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need for the development of a safer vaccine for the general public. In the case of a
bioterrorist threat, the reactogenicity of AVA would occlude safe and proper immunization
of certain members of society such as the young, and elderly. The safest measure to the
preparation of a subunit vaccine is recombinant DNA technology. In fact, a recombinant
version of AVA is already under clinical trials by the Food and Drug Administration, as a
pathogen free culture system to produce non-virulent antigens would represent the safest
approach to efficacious immunization. Though some criticize the approach of immunizing
against a single subunit representative of the pathogen, even including such component as
EF and LF severely limits the safety of vaccines against anthrax. Therefore, a next
generation vaccine strategy that is optimized for safe yet efficacious immunization is
required.
The bioterroist threat associated with anthrax warrants the need for immunization
approaches suitable for widespread use by the general public. The severe reactogenicity
and relative unavailability of Anthrax Vaccine Adsorbed (AVA), as well as the limited
supplies of Protective Antigen (PA), mandate the development of a better vaccine [35, 36].
In 2003, Jennifer Watson et al. of the Daniell Lab published their integration of the PA gene
pag with tobacco chloroplast [42]. Expression was driven by a light-dependant upstream
regulatory element psbA, and expression levels of 2.5 mg PA per gram of fresh leaf, or 14%
TSP, were achieved under continuous lighting conditions. Calculations provided an
extrapolated value of ~400 million vaccine doses per acre of crop. The bioactivity of this
antigen was demonstrated through a macrophage lysis assay, wherein the synergism
between plant-derived PA and anthrax derived LF killed host cells was retained despite the
plastid-source of PA [42].
12

In a subsequent study, Koya et al. evaluated the efficacy of this tobacco-derived
vaccine against anthrax. Using a mouse immunization model, purified plant-derived PA
preparation and B. anthracis derived PA were delivered in adjuvant subcutaneously, and
the induced immune response was measured. IgG titers of 1:320,000 were detected in both
test groups [43]. This serum was then subjected to toxin neutralization assay, where it
exhibited the capacity to inhibit lethal toxin formation from PA and LF. When exposed to
lethal doses of anthrax toxin, mice immunized with chloroplast derived PA in adjuvant
exhibited 100% survival rate for 200 hours post challenge.
This study demonstrates the potential of derived PA from transgenic chloroplasts.
While the final product is immunogenic, production is not costly and large amounts can be
farmed to produce enumerable doses. The latest study involving PA from the Daniell Lab
was the expression of this vaccine antigen in lettuce, which achieved expression of 22%
TSP [9]. While no evaluation of functionality was completed on this antigen, previous
demonstrations of plant derived PA demonstrate its bioactivity, and expressing such
vaccine antigens through edible crops could allow for oral administration of antigens and
subsequent immunization through the intestinal mucosa. Such orally vaccines would be
ideal in bioterrorism contexts, with respect to their ease of administration and minimal
downstream processing measures.
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Type-1 Diabetes and Recombinant Orally Deliverable Insulin
Diabetes mellitus is a group of diseases characterized by a decrease in pancreatic
beta-cell activity which is accompanied by hyperglycemia, or high blood sugar, and in
severe cases may lead to such complications as heart disease, kidney failure, ketoacidosis,
and stroke [44, 45]. Over 23 million Americans live with this disease, yet research has yet
to produce a cure. In 2007, Diabetes was the seventh leading cause of death, and in that
year healthcare costs totaled $174 billion in the United States alone. Most importantly, is
the cost of currently used recombinant insulin to patients, which might cost as much as
$100 a month [46].
In most cases, Diabetes is a result of aberrant insulin signaling resulting in the
deregulation of homeostasis. Type-1 Diabetes mellitus (T1DM) results when endogenous
insulin production is insufficient, or when the produced insulin is a mutated and inactive
form [47]. Insulin is the key hormone which stimulates the uptake of sugar from the blood
and its storage as glycogen. Malfunctioning insulin signaling therefore results in an
increase in basal blood glucose levels, and also in blood sugar spikes after meals, as they
are unable to cope with the sudden increase of sugar from their diet [47]. T1DM must
therefore carefully screen what they eat, as well as monitor their daily levels of blood
glucose. Patients with T1DM are frequently insulin dependant, meaning that they cannot
rely on endogenous and must therefore supplement themselves with other forms of insulin.
This process of daily finger-pricking for blood glucose measurements, followed by selfinjection of purified insulin, highlights the need for more comfortable means of disease
management for those afflicted with T1DM.
In some cases, the onset of Type-1 diabetes is the consequence of an autoimmune
14

response against the pancreatic beta-cells [44, 48, 49]. A few rare monogenic alleles, as well
as several susceptibility loci, have been implicated in this disease [45]. While the major
susceptibility locus identified is within the HLA genes encoding for host Major
Histocompatability Complex (MHC) proteins, other identified loci include the insulin gene
itself, Cytotoxic T-lymphocyte Associated Protein 4 (CTLA4), and Interleukin 2 receptor
(IL2R). The involvements of the above loci suggest that this disease is driven by a
breakdown in signaling efficacy of the immune response. Research has also strongly
suggested an involvement in viral infection during the initiation of the T1D disease state,
yet no direct link has yet been identified [47]. These susceptibility loci are often triggered
by environmental stimuli with many identified triggers of this autoimmune reaction.
Research has shown that certain dietary components could trigger the disease in
predisposed test mice; cow milk, particularly its albumin component, promotes β-cell
autoreactivty [45]. Another food antigen which initiates the auto reactive response is the
wheat protein gluten, though the effect was less than that observed by the cow milk.
Regardless of the sources of initiation of the various immune responses that
collectively characterize T1DM, the early phase of this pathology occurs largely unnoticed,
producing minimal symptoms. Bone marrow-derived lymphocytes, or B-cells, drive an
antibody response, which diffuses through the pancreas, opsonizing cognate autogantigens
[47, 49]. As the disease state progresses, however, CD8+ cytotoxic lymphocytes
supplemented by the cytokine meileu of CD4+ Helpter T-cells, infiltrate the organ and
mediate the destruction of the β-cells [48], which in turn eliminates the metabolic capacity
to regulate blood sugar. Several antigens have been identified as the key players in the
autoimmunity of T1DM: insulinoma-associated antigen-2 (I-A2), insulin (mIAA), glutamic
15

acid decarboxylase 65 (GAD65), and zinc transporter 8 (ZnT8) [49]. The presence of
several alternative autoantigens as the root cause of this disease complicates the matter in
such that therapies must therefore be customized on a patient level.
Insulin remains the most effective drug against both forms of Diabetes in today’s
market; however, management of this disease through insulin therapy is a tedious process
as patients literally walk the thin line between hyperglycemia and hyperinsulinaemia [47].
Compounding this difficulty is the fact that insulin is generally prescribed late in the
disease onset and that patient compliance is low. There is therefore a strong push to
develop new methods of insulin therapy, and oral delivery systems have become very
popular among pharmaceutical companies [50, 51]. Insulin has shown to possess
therapeutic potential in patients of both forms of diabetes mellitus. In T2DM patients this
therapy serves only to replace endogenous insulin, particularly the quick response insulin
response that many T2DMs lack in response to feeding. In T1DM patients, however, the
effects of insulin therapy further mediate an immunomodulatory response due to the
autoimmune nature of this disease [50, 51]. This mechanism, known as oral tolerance, is
becoming widely studied but is largely a dose dependant mechanism. Small antigen doses
drive a regulatory FoxP3+ T-cell response, whereas large antigen doses drive clonal
deletion and anergy of cognate T-cells; though these exist as disparate responses, research
has shown that the two cell-types are actually related and can readily interconvert if given
the correct microenvironments of TGF-β [52]. In either case, modifying the cellular actives
of insulin-activated T-cells through oral administration of insulin is a lucrative concept.
Several pharmaceutical companies have oral insulin products currently in clinical trials,
including capsule (Intesulin, Coremed), tablet (Eligen, Emisphere Technologies), and liquid
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forms (HIM-2, Nobex Technologies) [50]. These approaches generally utilize micro- or
nanaparticles made of such polymers as alginate, cyanoacrylate, and β-cyclodextrin. They
are often further optimized for human delivery through pegylation, protease inhibitors,
and pH responsive delivery systems. Oral delivery of insulin is likely to be the new phase of
Diabetes disease managements and will replace the discomforting habits of finger-pricking
and self-injection.
The first reported expression of a potential therapeutic treatment for diabetes
through a transgenic chloroplast approach came from the lab of Henry Daniell in 2007 [16].
Ruhlman et al. achieved stable homoplasmic integration of the human proinsulin gene
within lettuce and tobacco chloroplasts through pLD transformation meditated by particle
bombardment. Proinsulin (Pins) was fused to the Cholera Toxin B Subunit, which had
previously demonstrated oral adjuvant properties, through intertactions with GM-1
receptors in the gut [14]. The construct was expressed as the fusion protein (CTB-Pins),
and therefore possessed bivalent properties. In tobacco, CTB-Pins was placed under
control of the endogenous, light regulated promoter psbA. Expression levels were
unprecendtedly high and were reported to reach as high as 72% [9, 16]. In lettuce, the
expression cassette utilized the bacteriophage T7 gene10 promoter and accordingly
achieved lower expression levels of around ~24-25% [9].
Ruhlman et. al then evaluated the therapeutic potential for this plant-derived
human protein in a non-obese diabetic (NOD) mouse model which has onset of Diabetes
after twelve weeks. Using five-week old NOD mice, plant derived CTB-Pins was
administered orally in weekly doses for seven weeks. CTB-GFP, IFN-GFP constructs and
wild-type leaf material were gavaged to other control groups. After treatment, mice treated
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with the plant-derived Proinsulin construct had reduced lymphocytic infiltration of
pancreatic tissues; β-cells particularly were preserved when compared with negative
control treated mice. Furthermore, mice had lower blood and urine glucose levels,
suggesting a return of function to the pancreatic islets. Detection interleukin-4 and
interlukin-10 in the pancreas of CTB-Insulin treated mice suggests that the reduced
insulitis score was the product of T-helper 2 lymphocyte induction of tolerance, through a
subset of T-cell known as Regulatory T-cells (TReg).
This proof of concept caught on, and others began to replicate this therapeutic
model. Another Canadian group published plastid based expression of autoantigen human
glutamic acid decarboxylase (hGAD65) through the eukaryotic alga Chlamydomonas
reinhardtii during the next year [53]. Further research by the Daniell Lab produced a CTBPins construct with three inherent furin cleavage sites (CTB-PFx3) [46]. Upon endocytosis,
this therapeutic would be cleaved by endogenous pro-protein convertases, which would
process Proinsulin to active Insulin by cleave of the C-peptide. This platform was also
shown to reduce blood glucose levels, while the simultaneously delivered C-peptide is said
to confer protection from diabetic complications by stimulating nerve and renal functions.
Plant-derived insulin is a very appealing concept: while oral insulin is about to make
its debut in the pharmaceutical market, plants possess inherent capacity to resist gastric
digestion, thus making them suitable vehicles for delivery of antigen to the intestinal
mucosa. Furthermore, chloroplasts are completely capable of forming bioactive insulin
through the correct formation of disulfide bonds, which therefore represents an
inexpensive production platform. The innate characteristics of plant tissues, however,
occlude these plant derived therapeutics reasonable usage: considerable variability in
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expression levels, high water content, and protease activity produce widely variable
antigen yields. Furthermore, their short half-life under refrigerated conditions renders
them unsuitable for storage of an accumulated therapeutic. A method of batch
standardization, as well as long-term preservation for storage is therefore needed before
plant-derived insulin may be considered a relevant alternative to injectable forms so
widely used today.
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Lyophilization
Despite the increasing potential of plant-derived antigen-based vaccines,
researchers must consider several drawbacks associated with using plants as a vaccine
vehicle. Due to the high and varying water content of many edible plant materials,
delivering accurate doses is quite challenging. In addition, plants contain unusually high
concentration of proteases and secondary metabolites that will interfere with the
preservation of the transgenic antigen post harvesting. Thus, the shelf life of transgenic
protein (TP) in harvested leaves is usually short unless frozen. Considering these
shortcomings, it necessary to devise a method of plant preservation that serves to maintain
the therapeutic protein so that the many advantages of plastid based expression may be
utilized.
It stands to reason that the removal of water from these plant tissues may mollify
the problems associated with plant-based vaccines. In the absence of water, antigen
variability would normalize and proteolysis would be inhibited. Lyophilization, commonly
referred to as freeze-drying, is the removal of water from frozen tissue through
sublimation. In recent years, lyophilization has emerged has a promising means of plant
preservation [54, 55]. This procedure, which involves the freezing of the plant in a vacuum
and the slight addition of heat to sublimate all water directly out of the cells, serves to
effectively preserve the cellular protein content and even the appearance of the material.
Though Benedict and Manning first invented the lyophilizer in 1905, it was not until the
1970s that pharmaceutical companies and taxidermists saw the applications of this
procedure [55]. It is now widely used by biotechnology companies to produce preparations
of purified proteins for biomedical research.
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Today, lyophilization is widely used in preparing herbal supplements, foodstuffs,
pharmaceuticals, and biotechnology products. A review of this process given by Dr.
Dumitru Mnerie of the Polytechnica University of Romania, describes the pros and cons of
lyophlization [55]. While most biological processes are stopped in the frozen form, the ice
further promotes the maintenance of form and structure, contributing to the appealing
appearance of lyophilized products. However, freeze-drying is among the most costly of
drying methods, and possible alterations could occur to target molecules changing its
physical structure or chemical makeup. Mnerie notes that with high water content
foodstuffs such as lettuce, lyophilization is generally less efficient due to the high porosity
of the tissues [55].
Mnerie implicates the initial freezing step as critical to the success of the
lyophilization protocol in preservation. Even and consistent ice-crystal formation provides
a more appealing product. He continues to describe how the duration of this process relies
on two inherent factors of the tissue being dried: its conductivity, or how well it transmits
temperature and pressures, as well as its permeability. Lyophilization must therefore be
optimized for new materials. Sublimation occurs via minute temperature differences
between the sample environment and the condensing chamber. This reaction is driven by
the continuous reduction of vapor pressure in the vicinity of the sample, because the
vacuum is driving all vapors to the condenser where it is subsequently frozen. Drying may
essentially be broken into two processes; in the primary drying process the bulk of the
water content will be removed leaving approximately 5-7% residual water content. This
event may occur quite rapidly, but these levels of water are likely not appropriate for longterm storage. Therefore, a secondary drying process must be allowed to occur which may
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take considerably longer, but will help to reduce residual water content to a range of 1-3%,
acceptable levels of moisture for long term storage.
Many groups have already begun utilizing lyophilization measures within their
studies in one form or another. The first report of using lyophilization comes from the lab
of Amanda Walmsley in Milan, Italy. In 2003 Walmsley et al. published an article wherein
they applied lyophilized to nuclear-transformed Arabidopsis thaliana leaves to stabilize a E.
coli heat-liable Toxin B Subunit-ESAT-6 fusion antigen [56]. In this study, however,
lyophilization was applied mainly as a means to concentrate antigen content, as is the
intent of many pharmaceutical applications of this process. This group’s apparent lack of
interest in the preservative properties that lyophilization conferred to their antigen is
demonstrated by the fact that the lyophilized plant material was stored consistently at 20°C. However, Walmsley noted the increased level of antigen dose, as well as 4-month
stability at -20°C; an interesting demonstration was the GM-1 binding assay with 4-month
old samples in comparison to fresh samples. Lyophilization continued to be applied in
more instances: Mason et al. stabilized hepatitis B surface antigen (HBsAg) and Norwalk
virus capsid protein (NVCP) in transgenic tomatoes and potatoes through lyophilization
noting an increased immunogenicity of the virus-like particles when delivered orally to
mice [17, 20]. Webster et al. stabilized measles virus hemagglutinin (MV-H) derived from
transgenic lettuce and really completed the first in depth study of long-term antigen
stability and stability under extreme conditions: while MV-H was both stable at room
temperature for as long as 13 months, and at 50°C for a week. This freeze-dried lettucederived antigen still elicited potent immunoglobulin titers when administered as crude
extracts in conjunction with MV-H DNA mixtures [57]. Recently in 2010, Pniewski et al.
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took the first steps in formulating prototype orally administrable plant-derived vaccines
against hepatitis B virus (HBV) surface antigen (S-HBsAg) [58]. Not only did this antigen
form VLPs in vivo, but also it elicited high levels of anti-HBV specific immunity when
freeze-dried antigen was administered as oral boosts to the subcutaneous prime, without
adjuvant. After lyophilization, Pniewski et al. developed a tablet-based formulation using
polyvinylpyrrolidone/methylene chloride as a binding agent and lactose as excipient filler.
Though only a prototype formulation, this demonstrates the plausibility of this concept;
however, this group further demonstrated the efficacy of lyophilized plant-derived vaccine
antigens in immunization. In the cases of some nuclear transformed plants where levels of
expression are often lower than those of transplastomic plants, lyophilization serves to
increase antigen increasing the viability of such systems, as it was reported to produce a 7fold increase in antigen content [57].
This process can be applied to a variety of plants and tissues including leafs,
tomatoes, and potatotubers and has been shown to extend the shelf life of transgenic leafs
for up to a year at room temperature [20, 56, 58]. The current commercial uses of
lyophilization, as well as the obvious interests from other research groups, underscores the
potential of this technique. Lyophilization will be investigated herein, in order to develop a
capsule-type formulation to mediate oral delivery of plant-derived antigens. This is the first
report of using lyophilization to facilitate the stabilization of chloroplast-derived vaccine
antigens. Lyophilized antigens will be evaluated with respect to conformational integrity
and bioactivity; furthermore, the immunogenicity of this lyophilized vaccine is investigated
through a mouse immunization model. The use of lyophilization will be additionally
implicated during the formulation of oral capsules.
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OPTIMIZATION OF FREEZE DRYING
At the start of this study transgenic seeds were obtained from the Daniell lab seed bank
that were progeny of the original LS-HPAG and LS-CTBPins (L100) plant lines. These plants
were grown to maturity (Figure 1A.), and harvested at the time of peak antigen levels,
which was previously characterized, and immediately frozen in liquid nitrogen. At the time
of harvest, the relative water content of the fresh lettuce leaves was determined to be
69.5%, as depicted in Figure 1B. This information describes the relative turgidity of the
plant cells; while this measurement could vary between plants it is important to relate the
relative water content to the lyophilization parameter as it is a quick and efficient means of
assessing the water content of a sample. At this RWC, cells were determined to be ~95%
water, and ~5% dry cellular weight. Lyophilization treatment was optimized based on
relative gravimetric analysis of transgenic plants expressing PA and CTBPins. Incubation

Figure 1(A-C). (A) A mature, transplastomic lettuce plant (Lactuca sativa cv. Simpson Elite) expressing
Protective Antigen (PA) (B) Relative water content determined in FW leaf (C) The LabConCo 4.5L
Benchtop Lyophilizer used in this study.
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under lyophilization parameters of complete vacuum at -59° for varying durations of 24, 48
and 72 hours provided the extent of water removal with respect to time (Figure 1D). These
time points were chosen because the LabConCo manual suggested a 60-hour duration,
whereas other sources cited briefer treatments [55]. The freeze-drying system used in this
study was the LabConCo Freezone 4.5l

D.

Benchtop Lyophilizer (Figure 1C.)
Lyophilized plant material certainly
appeared a pale color in contrast to the fresh
leaf after lyophilization (Figure 1E.) Yet the
overall integrity of the leaf was preserved.
Relative weight reduction of the leaf samples with
E.

respect to time is given in figure 1D. While
differences in weight between the treated samples
could not be considered significant due to inherent
sample variability, it was clear that the control,
which was subjected to an oven-

1D.

drying parameter of 4 hours until constant weight
was achieved, contained no remaining
Figure 1 (D-E). (D) The reduction in sample weight
provided by differing lyophilization treatments. (E)
Qualitative comparison of fresh transgenic lettuce
leaf with lyophilized counterpart
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water and possessed less mass than the lyophilized samples. The percentage of the total
water remaining at each time point was then extrapolated, and compared to the oven-dried
control of 0%. Plotting this data provided a trend that depicts the extent of water removal
at each time point. After 24 hours
of lyophilization, .19% of water

F.
% Water Remaining

remained in the tissue. After 48
hours and 72 hours however,

0.2

that value was reduced to .058%

0.1

0.189

0.058 0.046
0.000

0

and .046% respectively. This

24 Hrs

indicated that at least 48 hours

48 Hrs

72 Hrs

Control

Lyophilization Treatmnet

was required to achieve the
maximal extent of water removal.

G.

% Water Removal

48 hours was determined to be
sufficient to completely

100

lyophilize these transgenic

99.8

lettuce lines, the percent of total

99.6

99.81
24 Hrs

99.94 99.95 100.00
48 Hrs

72 Hrs

Control

cellular mass that constitutes
transgenic protein was calculated
contrasted to that of fresh
transgenic lettuce. Based on

Figure 1 (F-G). (F) Depicts the extent of water
removal by lyophilization at each evaluated time
point. (G) is the converse plot of (F), indicating
the levels of water remaining in the tissues after
drying.

measurements made using LS-HPAG.
The fresh composition of lettuce was determined to consist of 95% water, 5% cellular dry
weight, and .02% antigen. Freeze-dried LS-HPAG was conversely only .06% water, 99.62%
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cellular dry weight, and therefore .33% pa. This figure gives a visual representation of the
increase in relative antigen content produced through lyophilization which will be
discussed further in later sections.

H.

Fresh Composition

I.

% Water

Freeze-Dried Composition

% Dry Weight

% Antigen

95.325%

99.6165%

0.0548%

0.014%

4.660%
0.3287%

Figure 1 (H-I). This information obtained from gravimetric analysis of lyophilized tissues was
used to derive (H) and (I) which provide the composition of fresh and freeze-dried lettuce
materials
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ANTIGEN LEVEL STANDARDIZATION
In order to work with these proteins in a quantitative manner, standarization of
antigen levels was necessary. For fresh weight (FW) and freeze-dried (FD) LS-HPAG, the
Enzyme-Linked Immunosorbent Assay was used to quantify PA levels by correlation to a
purified standard of B. anthracis derived PA. The Bradford assay was used to determine
levels of total protein. FW LS-HPAG
expression was measured at 3.5-

A.

Protein Content of Transgenic Lettuce
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1400

4.5% TSP, which equates to
1350

approximately 140 micrograms per
gram of leaf. The DW composition

Total Protein

1250

was nearly 24-fold higher, indicative

1200

of the considerable reduction in

1150

relative water content. Due to the

Protective Antigen

1300

Fresh Weight

B.
1750

stable state of the lyophilized

1650

lettuce, further homogenization was

1550

possible using a simple coffee mill;

1450

this device was capable of producing

Freeze-Dried

B.

CTB-Pins
Total Protein

1350
1250

coarsely crumbled leaf pieces
(Figure ) or refined leaf powder
when grinding time was extended
and leaf was passed through a sieve.

1150

Fresh Weight

Freeze-Dried

Figure 2 (A-B). (A) Depicts the protein content of FW and
FD LS-HPAG tissues; a TP expression of 3.5-4.5% TSP was
observed in this plant line (B) Protein expression profile
of LS-CTBPins; expression in this plant line was observed
at 10-11%.
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This highly homogenous sample set enabled very accurate estimation of the entire batches’
antigen content as is demonstrated through the normalization of LS-HPAG antigen content
(Figure 7). The normal distribution of measured antigen content in lyophilized samples
becomes more precise, and the standard deviation decreases. Quantification of CTB-Pins
through ELISA is not possible due to the insoluble nature of this particulate antigen;
therefore, densitometric analysis in conjunction with the Bradford assasy was used to
estimate levels of expression in this line. Duplicates of serially diluted CTB-Pins extract
were boiled for 15 minutes to denature tertiary structures and oligomers and was loaded
in SDS-PAGE and run alongside CTB standards. Spot density evaluation enabled for
accurate estimation of CTB-Pins Levels, which provided levels of expression around 10%
TSP, or an equivalent of 13.3 mg/g.

1 2

3 4

5 6 7

8 9 10 11 12

C.

Figure 2(C) (C) Western blot of CTB
standard and CTBPins extracted
(serially diluted) used in the
quantification of this plant line; the
standard curve obtained through
densitometric analysis is provided.
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LONG TERM ANTIGEN STABLIZATION
The shelf life of plant-derived antigens
is of major concern in relation to the

Freshly Lyophilized

A.

1 Year Old

distribution of biopharmaceuticals to rural
areas. Inures where shipments may be
infrequent, and cold-chain storage is simply
unavailable, the shelf life of plant-derived
antigen is highly important and could affect the proportion of the population which
receives proper treatment. After lyophilization, plant-derived antigen was evaluated for
long-term stability through SDS-PAGE using rabbit anti-PA antibody. After one year of
room temperature storage in the dark, the appearance of the freeze-dried material had
decreased levels of green pigment. It appeared
B.

paler and yellow than freshly lyophilized

100ng PA WT FW

24

48

72
83 kDa

tissues (Figure 3A). However evaluation of
antigen integrity demonstrated good
preservation of both PA and CTB-Pins. 3 ug

C.

100ng PA WT FW

1

2

3

loads of FD LS-HPAG of two, four, and six

83 kDa

months of age were compared to FW LSHPAG, and there were no observable
degradation products in the lyophilized
samples. Furthermore, 6-month-old samples
that were differentially treated in regards to
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Figure 3 (A-C). (A) demonstrates the
qualitative change in appearance of
lyophilized leaf material over the course
of 1-year. (B) 6-month old tissues
lyophilized for varying durations
evaluated for antigen stabilization. (C)
FD LS-HPAG that is 2, 4 and 6 months
old respectively (1,2,3).

lyophilization duration (24, 48, and 72 hour) were evaluated through SDS-PAGE. Again, no
observable significant difference exists between the FD and FW samples. Interestingly
however, 24 Hrs provided levels of stabilization indistinguishable from those of 48 and 72hour treatments, suggesting that maybe this treatment was indeed sufficient. Evaluation of
one-year-old FD LS-CTBPins provided similar results, demonstrating the efficacy of this
freeze-drying process in maintaining antigen integrity.
FW and FD PA were subsequently evaluated through comparative SDS-PAGE and
Native (non-denaturing, non-reducing) gels to examine potential conformational changes,
or sugar linkages that occurred during lyophilization. Both FW and FD PA migrated
similarly on gels regardless of their denaturing or native properties. This data suggests that
no major conformational modifications are bestowed on PA during the freeze-drying
process, which further authenticates this approach’s benefits for plant-based vaccines.
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Figure 3 (D-F). (D) Displays the
stability of 1-year old FD LS-CTBPins
(7-9), in comparison with FW LSCTBPins (5-6) and CTB standard (1-4).
(E) Demonstrates that FW and FD PA
migrate similarly during SDS-PAGE.
(F) Demonstrates that FW and FD PA
migrate similarly during native gel
electrophoresis, indicating that now
protein modification occurred during
lyophilization.
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PHOTOSENSITIVITY OF LYOPHILIZED MATTER
The cell-death induced by freezing immediately jeopardizes the integrity of
chlorophyll within the light harvesting complexes on the plant cell membranes. Therefore,
the gradual depletion of green vitaility has previously observed in Figure 1E is to be
expected. However, the observation that a FD sample left on

A.

the desk was being bleached by the sun led to the
investigation of potential antigen sensitivity through the same
oxidative mechanism. A sample of FD LS-HPAG was exposed
to direct sunlight for 3 months. First, levels of chlorophyll A
λ

and chlorophyll B were evaluated through methanol/acetone
extraction and evaluation of absorbtion at 650/640. It was
observed that not only had the freeze-drying process
significantly depleted endogenous chlorophyll, but the
photobleached sample had been completely abrogated. To
B.

Relative Chlorophyll levels
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Figure 4 (A,B). (A) A major
qualitative
change
in
lyophilized material was
observed in response to
prolonged sun exposure. (B)
Chlorophyll
is
partially
degraded
during
lyophilization, but remaining
stores in lyophilized tissues
are sensitive to lightexposure.
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DW-Ls-HPAG

Photobleached DW-Ls-HPAG

investigate the potential photo-oxidation of Protective Antigen, extracts of the
photobleached sample were compared with those of FD and FW tissues in order to contrast
the antigen integrity. While SDS-PAGE analysis suggested slight degradation of target
protein, ELISA refuted any significant difference between the PA content of these tissues.
Together, this data means that while endogenous secondary metabolites of the plant may
be sensitive to photooxidative mechanisms, the target antigen PA was uneffected by light,
and was therefore stable under minimalistic storage conditions.
FW
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Figure 4 (C,D). (C) depicts
stability of PA in photobleached
samples in comparison to FW (13) and 48-Hr FD (4-6) controls.
(D) quantification of PA in the
same tissues through ELISA
provided no significant difference
between FD LS-HPAG and the
photobleached sample.
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PROTECTION OF ANTIGEN FROM GASTRIC DIGESTION
Of the major impediments to oral immunization is the digestibility of target proteins
in the human gastrointestinal tract; the viability of this vaccine technology depends on
successful delivery of target protein to the small intestine. Plant cells, impervious to human
digestive enzymes, accordingly protect protein from proteolysis through a mechanism
termed bioencapsulation. Bioencapsulation, though long argued for by plant-based vaccine
proponents, has not been previously demonstrated in plants.
Recent efforts to characterize certain defining characteristics of food allergens and
to evaluate allergenicity of transgenic food proteins has resulted in the development of an
accurate in vitro representation of gastric digestion, as a means to evaluate a protein’s
potential to persist through the stomach and subsequently induce an IgE mediated allergic
reaction in the intestinal mucosa. The survival of the protein through Simulated Gastric
Fluid (SGF; 0.2% NaCl, 0.7%HCl, 0.32%Pepsin, pH1.2, 37°C) indicates a proteins potential
role as a food allergen. The SGF assay may therefore be applied to plants bearing antigen
subunit vaccines to asses the protection conferred by the plant cell vector through
bioencapsulation.
Plant-derived protein was be exposed to digestive conditions in a 37°C water bath
for a one-hour time frame with samples taken at time points (0, 5, 30, 60, 300, 900, and
3600 seconds). At each representative time-point, sample digestion was quenched through
the addition of Tris-Cl buffer supplemented by a protease inhibitor cocktail (Roche) prior
to protein isolation and analysis via SDS-PAGE and Western Blotting. This reaction quench
raises the pH such that Pepsin assumes an inactive conformation, and the protease
inhibitor further inhibits target protein degradation. While Pepsin possesses no catalytic
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ability to degrade cellulose, the combined effects of acid hydrolysis, hypertonic pressure,
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Figure 5 (A-E). (A) SGF assay on purified, bacterial PA; while severe degradation is
observed in the first 30 seconds no antigen is detectable beyond 1 minute. (B) Tobaccoderived PA, in the SGF assay; tobacco provided substantial antigenic protection through
bioencpasulation. FW (C) and FD (D) LS-HPAG also demonstrated significant levels of
antigen protection like tobacco. Loads: 1-(-) control, 2- 5 sec, 3- 30 sec, 4- 60 sec, 5- 300
sec, 6- 900 sec, 7- 3600 sec, 8- (-)F, 9-Q.

and activation of endogenous protease machinery could lead to degradation of target
protein.
Despite these digestive pressures, plant-derived bioencapsulated PA was protected
throughout the one-hour digestion time course, while purified PA was rapidly degraded
within one-minute. FD material did not experience degradation of target protein indicating
that the lyophilization process maintained membrane integrity such that too it was capable
of facilitate intestinal delivery of antigens, despite the freezing-steps implicated in the
treatment process. Furthermore, the protection conferred by lettuce cells was qualitatively
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similar to that provided by tobacco cells in the. This observation authenticates the potential
role of lettuce as an edible vector for oral immunization. The representative image
provided in Figure 5E displays the observed color change promoted during digestion. The
depletion of the green color in this image is representative of the gradual destruction of cell
walls, and consequently the light harvesting complexes, which results in the gradual
depletion of chlorophyll. The differential preservation of the green color, indicative of
chlorophyll, was rapidly depleted in time point samples, however the quenched sample (Q)
which was supplemented with pepsin neutralization before exposure to the digestive juices
maintained green color despite 1-hour incubation at 37˚C. While (-) and (-)F (treated with
pepsin- SGF) demonstrated the same color change in a time dependent manner, this data
indicates that the synergism of acid hydrolysis and osmotic potential within the stomach is
sufficient to drive the disruption of cell walls.

Digestion Duration
(-)

5 sec

30 sec

60 sec

300 sec

900 sec

3600 sec

(-)F

Q

E.

Figure 5 (E) Qualitative representation of the effects of digestion of plant
tissues bearing antigen. (-) samples represent incubations in acidic SGF in
the absence of pepsin, Q sample represents SGF/Pepsin mixture that was
neutralized prior to 1 hour incubation. Time points from 5 seconds to 1
hour.
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IMMUNOGENICITY OF LYOPHILIZED PLANT DERIVED PROTECTIVE
ANTIGEN
While lyophilized PA had maintained its structural identity through lyophilization,
and previous publications demonstrated the bioactivity of plant derived PA, a mouse
immunization model was adopted to evaluate the immunogenicity of lettuce derived PA, as
well as that of FD-PA. Using an immunization regime consisting of a subcutaneous
primovaccine followed by oral boosting with plant derived PA, mice were immunized
against anthrax. Induction of IgG in serum was monitored over the course of the
immunization experiment. FD LS-HPAG immunized mice produced higher antibody titers
than its FW counterpart; additionally, sera from mice immunized with FD LS-HPAG
demonstrated the ability to neutralize LT in the toxin neutralization assay. As expected,
mice immunized by FD PA demonstrated the highest survival rate (40%) when challenged
by 1.5LD100 cfu aerosolized spores, in comparison to FW immunized mice (20%), and FW
immunized mice who didn’t receive the primovaccine (0%). The group that never received
Figure 6 (A). IgG titers of
test groups in mouse
immunization model after
12-weekly gavage boosts;
plant-derived antigen that
was
preceded
by
a
subcutaneous
prime
initiated the most potent
immune response.

A.
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the subcutaneous prime likely promoted the induction of a TH2 cell mediated Treg
response upon oral antigen uptake. This data indicates that immunogenicity is at least
preserved through lyophilization; whether lyophilization helps increase the
immunogenicity of antigens remains to be seen, however previous reports have suggested
this concept [58]. Lyophilization is therefore an effective means to stabilize plant-derived
vaccine antigens.

Figure 6 (B-C). (B) Evaluation of only the group that was immunized by FD LSHPAG; maximal response was reached by week 10. (C) Toxin neutralization
assay data of sera obtained from the mice of this immunization study. Data
obtained agrees with previously characterized IgG titers.
B.

C.
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D.

Figure 6 (D). Lethal toxin challenge of mice immunized by different
combinations of FW LS-HPAG (prime vs. no prime) and FD LS-HPAG.
S.c. injection elicited the highest immune response and accordingly
provided the most protection, while mice boosted by FD LS-HPAG
were bestowed with the second most effective response geared
towards anthrax.
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FORMATION OF ORAL CAPSULES
As this field develops, it is becoming more apparent the original concept of “edible
vaccines” may never be achievable. It is essential that immunization procedures be
characterized and strictly followed in order to properly confer immunity and to avoid the
induction of antigen tolerance. Therefore, much control must be exerted over the delivery
of plant-derived vaccines and material must be produced in a consistent manner. To do
this, antigen-bearing material must be formulated into capsules or tablets for the efficient
and regulated distribution of this type of vaccine. When considering the many options
available for producing these objects, there are many possibilities of formulations,
stabilizing agents, or additives that could increase the efficiency of delivery and thus the
efficacy of plant-derived vaccines.
Capsules are an inexpensive and frequently used method of producing plant
supplements or vitamins. In contrast to tablets which require binding agents and expensive
production units, capsules require minimalistic processing of the leaf and can tolerate
mildly heterogeneous leaf powders. Instead of grinding by mortar and pestle, a simple
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a capsule-filling system to produce gelatin capsule of biopharmaceuticals. While commonly
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used gelatin capsules that will simply release in the stomach, complex options are available
with targeted releases; one example is a pH dependent release system wherein the
ingested capsule does not dissolve until it reaches the pH of the intestinal lumen.
Additionally, other biopolymers such as chitosan have demonstrated potential to protect
protein-based therapeutics during oral delivery. Capsules made from such polymers could
improve the bioencapsulative protection of target protein. Simple powdered adjuvants
such as crude saponins may be processed into these capsules to promote the formation of
an oral immune response. Lactose and other inert excipients may be added to produce
specifically catered antigen doses, in order to specialize delivery for either children or
adults. Lyophilization enables easy and stable processing of plant-derived vaccine antigens
into formulations conducive for oral delivery. Further improvements of this proto-type oral
formulation may be studied, using lyophilization of plant-material as the means to generate
stable recombinant antigens.
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CONCLUSIONS
The inherently high water content of lettuce cells that constitutes ~95% of its fresh
weight generates an environment unfavorable to the accumulation of target protein in
transgenic plant systems. Lyophilization was therefore applied to transgenic plant tissue
with the intent to preserve target protein in a stable form through the removal of water.
Characterization of the relative water content of harvested lettuce provided that cells of
Lactuca sativa leaves maintain turgour pressure at only 70% of their maximal capacity;
however, this large ratio of water to cellular dry weight dilutes target proteins and
provides conditions favorable for proteolysis. The application of lyophlization is known to
efficiently reduce the water content of plant material and was investigated for its potential
to abrogate the drawbacks of plant-tissue vectors.
While sources in literature suggested that lettuce was particularly recalcitrant in
lyophillization, and that a 60-hour treatment might be required for optimal drying, 48hours of lyophilization was shown to be sufficient in the experiments herein. Oven-dried
control samples suggested that the cellular dry-weight of fresh plant tissues was roughly
4.6% of the overall fresh weight. Gravimetric analyses of lyophilized samples before and
after treatment provided the reduction in weight generated by each time point. While
simply examining the reduction in weight, the differences between different time points
provided no significant differences; however, a cross-comparison with controls allowed the
determination of the percent of initial water remaining in lettuce at each time point, and
conversely the percentage of water removal accomplished by that point. While data
indicated that 24-hours reduced water levels to .2% of the original level, and therefore was
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99.8% efficient, 48- and 72-hours provided a further 4-fold decrease in water content.
These periods of treatment were found to reduce the weight of tissue samples to 4.92%
and 4.91% of their original weights respectively. This corresponded to .058% and .046% of
total remaining water suggesting that 48-hour treatment was 99.94% efficient, and 72hours was 99.95% efficient. While the differences between the two and three day
treatments were minimal, they provided a clear reduction in weight over those samples
treated for only one-day. The 48-hour treatment was therefore chosen as the optimal
treatment for the transgenic lettuce lines used in this study. As described previously,
lettuce tissues lyophilized for 48-hours still contain .058% of their original water content;
this drastic reduction in water content increased the cellular dry-weight of fresh material
from 4.6% to 99.6%. This increase additionally corresponded to a 20-fold increase in the
target protein content in plants bearing vaccine antigens.
In fresh-weight tissues, high-water content produces variability of antigen levels
with respect to biomass and occludes easy normalization of antigen levels. Removal of
water through lyophilization facilitated easy homogenization of freeze-dried tissues. While
homogenization of fresh tissue generates cell lysates with rapid proteolysis, the
homogenization of freeze-dried tissues in a coffee mill produced a finely ground powder
characterized by stable antigen. This homogenization step can facilitate normalization of
antigen batches, as was demonstrated herein. Despite the 20-fold increase in antigen
content, variability across samples was reduced when transgenic protein levels were
determined through ELISA or densitometric analysis.
An evaluation of the integrity of lyophilized plant-derived antigens after extended
periods of storage at room temperature demonstrated their stabilization through
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lyophilization. 48-hours of freeze-drying generated stable antigens for over a year, under
desiccated storage parameters. Comparison of protein extracts obtained from one-year old
lyophilized protective antigen through SDS-PAGE and non-denaturing, non-reducing native
poly-acrylamide electrophoresis showed no significant difference between fresh and
lyophilized antigen. This verifies that antigen conformation is maintained during the
freeze-drying treatment, which suggests that immunogenicity of the vaccine antigen is
maintained. This further demonstrates that no linkages between the target protein and
reducing sugars are induced via the removal of water, as some sources have suggested as a
possible drawback of lyophilizing proteins within plants.
Though lyophilized plant-derived antigens were stable under specific storage
parameters, samples exposed to sunlight demonstrated the photosensitivity of the crude
product. A depletion of green pigment was observed, which was subsequently correlated
with a depletion of endogenous chlorophyll. A comparison of chlorophyll levels between
fresh lettuce, lyophilized lettuce and the photobleached samples characterized the effects
of lyophilization of other endogenous metabolites. Lyophilization induced a dramatic
decrease in chlorophyll levels, likely due to the rapid freezing by liquid nitrogen associated
with the freeze-drying process. Freezing ultimately drove the rupturing of cellular
membranes, which resulted in the disruption of light harvesting complexes (LHCs) within
plant cells. While unstable outside of the LHCs chlorophyll rapidly oxidizes, the likely
occurrence that provides the observed decrease in endogenous chlorophyll. Chlorophyll in
photobleached samples was below detectable levels, which appropriately describes the
observed qualitative change in the plant material. This observation led to investigation of
transgenic antigen stability with respect to photooxidation. Lyophilized PA demonstrated
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no such sensitivity and was found to be stable in lyophilized tissues even after three
months of direct sunlight exposure.
While the survival of gastric digestion is critical to the success of the oral delivery of
any therapeutic protein, the highly proteolytic environment of the stomach occludes
efficient oral delivery of proteinaceous therapeutics. Bioencapsulation by plant cell walls
has been openly discussed as a viable mechanism for antigen delivery to the gut, yet
experimental demonstration of this phenomena has yet to occur. The simulated gastric
fluid assay was applied to evaluate the potential of plant-cell vectors to deliver antigen in
this context. Purified antigens were used for assay optimization and standardization; nonbioencapsulated antigen was rapidly digestion within one-minute of exposure. Conversely,
plant-derived antigens were shown to be stable and detectable via immunoblotting after
one-hour of exposure to digestive conditions. There were no significant differences
conferred by lettuce versus tobacco cell walls, demonstrating that lettuce is a viable
alternative to this platform, despite the fragility of this plant. Digestion produced a fade in
visible chlorophyll that directly correlated to the duration of digestion, which suggests LHC
and by association the degradation of cell walls. This exhibits a protective property
conferred solely by the chloroplasts as no deterioration in antigen is observed and
indicates that further investigation into chloroplast stability during digestion should be
investigated. The SGF assay utilized herein accurately assesses the potential for oral
protein-delivery through this system and substantiates the proof of concept for the oral
delivery of plant-derived biopharmaceuticals.
The immunogenicity of freeze-dried plant-derived antigens was maintained for up
to a year, corresponding to the preserved integrity of the protein. Mice immunized by oral
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boosting of lyophilized lettuce derived PA after a subcutaneous primovaccination
developed a measurable 2000-fold titer induction of IgG molecules in response to PA. This
significant response increased with each subsequent oral delivery of plant-derived PA,
demonstrating that the oral delivery of antigens bioencapsulated by plant cell walls is an
efficient means of boosting immunizations. However, the lack of immunogenic response in
mice that received oral boosting without primovaccination underscores one of the main
impediments to purely oral immunization strategies. The general induction of tolerance
against antigens within the gastrointestinal tract occludes efficient immunization without
prior priming of an adaptive immune response. The addition of adjuvants that promote the
induction of immunity could improve this efficiency; however, the mechanisms that
regulate mucosal immunity are poorly understood. Therefore, rational design of
therapeutics is difficult. Furthermore, the sharp contrast of survival rates in animals which
received subcutaneous immunization (100%), against animals that were boosted orally by
freeze-dried PA (40%), implies that the uptake of antigen within the intestinal mucosa is
inefficient. In previous studies that utilized receptor-mediated forms of delivery, such as
the CTB vaccine against cholera, the titers of orally immunized animals were more
consistent with that of sc. injected mice. The titers induced via receptor-mediated delivery
methods were more consistent across animals, whereas mice that received orally boosted
PA were very disparate between mice. This demonstrates the requirements for improved
antigen delivery methods to the gut; the development of other receptor-mediated
approaches that are compatible with large proteins such as PA could drastically improve
animal survival rates. Another research group with a probiotic, Lactobacillus acidophilus,
approach to PA immunization tackled this issue by incorporating a dendritic cell targeting
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peptide, which they identified through reverse-phage display libraries, as a fusion antigen
to mediate antigen delivery. Strikingly, PA when delivered alone induced only 40% survival
rates in animal, in agreement with our findings. However, the incorporation of the DCtargeting domain improved survival by two-fold, conferring protection to 80% of animals.
This study highlights the importance of improved methods in mucosal antigen delivery. A
final observation with respect to the mouse-immunization is that the freeze-dried PA
induced higher titers than its fresh counterpart. Lyophilization could have increased the
immunogenicity of the antigen by changing its conformation in some way, such as forming
particulate antigen. However, it is also possible that lyophilization only altered the
digestibility of this antigen. In either case, the differences in immunization efficiency by
fresh and freeze-dried plant-derived antigens should be investigated further,
The dried state of the plant material after lyophilization facilitated refined
homogenization of the plant material, while maintaining its stability at room temperature.
In addition to normalizing the batch antigen content of this material, the refined form of the
plant material could be quickly processed into gelatin-based capsules, as the vehicle for
oral delivery. Such capsules would allow for the inclusion of excipient additives. Fillers
such as lactose may be used to develop specific antigen doses and specialized vaccines for
adults or children. Hygroscopic additives facilitate the swelling of the capsules and the
release of the plant contents, and use of pH-specific capsules would enable targeted release
directly to the small intestine. All such improvements to this technology may now be
examined due to the formulation of this plant-derived antigen after lyophilization.
Lyophilization proved to be a useful means of preserving plant-derived vaccine
antigens. In addition to being stable during prolonged room-temperature storage,
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lyophilization facilitated the processing of crude harvested-leaves into a refined capsule,
while simultaneously eliminating bacterial flora and providing a 20-fold increase in antigen
content. These effects synergize to eliminate a significant portion of downstream
production costs; therefore, this technique could lower the general cost of therapeutics or
vaccines to make the more accessible to the general public.
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METHODS
Lyophilization optimization.
Frozen tissue was subjected to partial homogenization, mainly to disrupt large pieces of
leaf in order to ensure relatively equal surface-area to volume ratios. When this was not
done drying process produced dark patches of concentrated pigments localized at the
interior of the leaf, likely a result of gradual depletion of water from the peripheral edge of
the leaf (Not shown). This crumbled material was then transferred into either 50-mL or 15mL falcon tubes and sealed with 3M Millipore Medical Tape. This tape possesses small
pores designed provide air to healing wounds, but was used in this situation as a barrier
transmissible by evaporating water yet not by plant material. Samples were transported to
the lyophilizer on liquid nitrogen and treated for varying durations of 24, 48 and 72 hours.
Optimization based on %water removal, measured through relative gravimetric analysis.
Lyophilization occurred at -58 C, under vacuum conditions. Optimization was completed
through comparative gravimetric analysis.
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Protein extraction
Protein extraction was completed at a ratio of 100mg FW leaf/ 300 ul of Plant Extraction
Buffer, or at a ratio of 5mg DW leaf/300 ul PEB. PEB components include NaCl, EDTA, 1M
Tris HCl pH 8.0, tween-20, β-mercaptoethanol, dithiothreitol, Sodium dodecyl sulfate,
phenylmethylsulfonylfluoride and protease inhibitor cocktail. Tissue homogenization was
completed through sonication at 5 W for 3 bursts of 5 seconds each.
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Western blotting:
SDS-PAGE gels were cast in varying mixtures of Tris-Cl and acrylamide. Protein samples
were mixed with either 2X Laemelli or 6X Laemelli reducing buffer, before being boiled for
10-15 minutes. Samples were immediately loaded onto gel and run. After transfer to
nitrocellulose membrane, western blotting protocol was completed. Briefly using a 3%
PTM solution the membrane was blocked for 1 hour before the addition of primary
antibody for an overnight incubation (1:3000, PA: rabbit anti-PA, CTBPins: rabbit antiCTB). Secondary antibody (1:5000 goat anti-rabbit, Southern Biotechnology) was added for
1.5 hours have rinsing off unbound primary antibody. Lastly, chemmiluminescent (Thermo
Scientific) substrates provided for film-based detection of protein signals.
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ELISA
Quantitative: Protein extract homogenates are centrifuged to remove particulate matter,
and the resulting supernatants are diluted serially around levels of 1:5,000. These dilutions
are related to a standard curve of purified PA in order to derived an accurate estimation of
the unknown amount. This comparison occurs through a similar immunoblotting approach
as the technique described above, which utilizes a primary antibody to recognize antigen,
followed by a secondary antibody conjugated to Horse Radish Peroxidase (HRP). Antigen is
first coated on the plate overnight in a 100 ul volume. Then blocking, primary and
secondary all occur for one hour at 37°C with intermittent washes by water and phosphate
buffered saline. Signal detection here is accomplish with the substrate 3,3’-5,5’
tetramethylbenzidine which gets converted to a blue compound by HRP, but then assumes
a yellow producing conformation up stopping the substrate reaction with 2 normal sulfuric
acid. The plate is read at 450nm to detect the yellow color.
Antibody Titers: In this catenation of the ELISA, the plate was first coated with purified
antigens, and test mouse sera was evaluated for its ability to recognize PA. Mouse Fc
regions were then recognized by rabbit anti-mouse secondary antibodies, and plate was
read at 450nm.
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Bradford Assay
In the Bradford assay protein extracts are serially dilute with known concentration of
bovine serum albumin (BSA), in order to determine the concentration of total protein in a
mixture. Therefore a derivative of coomassie blue is used as the detection agent here, as it
interacts nonspecifically with aromatic amino acids. The level of blue intensity between the
defined standard and the unknown may be correlated by reading at 595 nm.
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Densitometric Analysis
Quantification of CTB-Pins immunoblots was accomplished using a CTB standard protein
(Sigma) at concentrations 0f 25, 50, 100 and 150ng. Volumes of .625 ul decreasing serially
for 4 samples were evaluated. Using Alphaimager and Alphaease FC software, the levels of
CTB-Pins were quantified.

54

Chlorophyll extraction
Fresh tissue was ground in an autoclaved mortar and pestle in a methanol/acetic acid
mixture until no major particles remained in solution. This extraction was then serially
diluted and the absorbance was read at both 650 and 640 which gave the levels of
Chlorophyll A and Chlorophyll B. The absorbance was related to a chlorophyll level based
on a constant value of define chlorophyll absorbance.
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Simulated Digestion assay
Simulated Gastric Fluid (SGF; 0.2% NaCl, 0.7%HCl, 0.32%Pepsin, pH1.2, 37°C) was
prepared, and either 1ug of purified PA or plant derived PA was subjected to a 200 ul
digestion volume that remained at 37°C for a determined period. Quenching of digestion
occurred by Tris/Protease inhibitor cocktail addition, then storage on ice. After digestion,
protein extraction occurred via a 1:1 addition of PEB, followed by sonication as previously
described. Results were evaluated by loading 50ng of protein for western blotting.
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